Oslo University Hospital / Oslo Universitetssykehus Rikshospitalet

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) Liu J, Prager-van der Smissen WJ, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, et al. Journal article 2019 ESC Guide on the Diagnosis and Treatment of Chronic Coronary Syndromes (2020) Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, et al. Journal article EFFECT OF NINTEDANIB ON PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED ILDS: FURTHER DATA FROM THE INBUILD TRIAL (2020) Matteson E, Kelly C, Distler J, Hoffmann-Vold AM, Seibold J, Mittoo S, Distler O, et al. Conference contribution Criteria for defining interictal epileptiform discharges in EEG: A clinical validation study (2020) Kural MA, Duez L, Sejer Hansen V, Larsson PG, Rampp S, Schulz R, Tankisi H, et al. Journal article Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7 (2020) Castilla-Vallmanya L, Selmer KK, Dimartino C, Rabionet R, Blanco-Sanchez B, Yang S, Reijnders MRF, et al. Journal article Predictors of progression in systemic sclerosis patients with interstitial lung disease (2020) Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler J, et al. Journal article, Review article The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements (2020) Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, Bruni C, et al. Journal article A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, et al. Journal article 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes (2020) Knuuti J, Wijns W, Achenbach S, Agewall S, Barbato E, Bax JJ, Capodanno D, et al. Journal article, Review article A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. (2020) Dangas GD, Tijssen JGP, Woehrle J, Sondergaard L, Gilard M, Moellmann H, Makkar RR, et al. Journal article